BofA Global Research Raises Biogen Price Target to $244

On October 22, 2026, BofA Global Research raised its price target for Biogen Inc. (ticker: BIIB) from $219.00 to $244.00. This adjustment is based on the firm's updated analysis of the company's valuation and does not indicate any changes in Biogen's fundamental business operations or guidance.